The safety and effectiveness of Casodex in women has not been studied. The safety and effectiveness of Casodex in children has not been studied. The safety and effectiveness of Casodex in children has not been studied. These pharmacological eftects have been observed with other antiandrogens. There is no evidence of hepatic enzyme induction in patients receiving a daily dose of 150 mg.
Abnormalities are usually reversible upon discontinuation.
No causal relationship of these experiences to drug treatment has been made and some of the experiences reported are those that commonly occurr in elderly patients. Other changes were reported with similar incidence in both treatment groups. It should be remembered that in this patient population multiple drugs may have been taken. General supportive care, including frequent monitoring of vital signs and close observation of the patient, is indicated. No dosage adjustment is necessary for patients with renal or mild hepatic impairment.